{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:22:06Z","timestamp":1779358926552,"version":"3.51.4"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T00:00:00Z","timestamp":1494892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Communications"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>Primary biliary cholangitis (PBC) is diagnosed mainly in female individuals, and risk factors for PBC recurrence (rPBC) after liver transplantation (LT) from cadaveric donors have been reported. We conducted a retrospective multicenter study of rPBC in female patients after living\u2010donor LT (LDLT). A total of 388 female patients undergoing LDLT for end\u2010stage PBC were enrolled, and the effects of preoperative and operative factors were evaluated. Postoperative factors were evaluated in 312 patients who survived for more than 1 year post\u2010LDLT. rPBC was defined as abnormal hepatic enzyme levels with typical histological findings in liver biopsies. Fifty\u2010eight patients (14.9%) developed rPBC with a median of 4.6 (0.8\u201014.5) years post\u2010LT. Cox hazard analysis (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.05) showed that younger recipient age (hazard ratio, 0.95; 95% confidence interval, 0.920\u20100.982), shorter operative time (1.00; 0.995\u20100.999), higher serum immunoglobulin M level (1.00; 1.001\u20101.002), donor sex mismatch (2.45; 1.268\u20104.736), human leukocyte antigen B60 (2.56; 1.336\u20104.921) and DR8 (1.98; 1.134\u20103.448), and initial treatment with cyclosporine A (3.14; 1.602\u20106.138) were significantly associated with rPBC. The frequencies of Child\u2010Turcotte\u2010Pugh class C (0.46; 0.274\u20100.775), the model of end\u2010stage liver disease score (0.96; 0.914\u20100.998), and updated Mayo risk score (1.02; 1.005\u20101.033) were significantly lower in rPBC. Posttransplantation use of steroids decreased and that of antimetabolites increased the frequency of rPBC. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: The timing of LT, recipient conditions, donor characteristics, and immunosuppressive medications may be associated with rPBC in LT recipients. (<jats:italic toggle=\"yes\">Hepatology Communications<\/jats:italic> 2017;1:394\u2013405)<\/jats:p>","DOI":"10.1002\/hep4.1037","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T10:42:45Z","timestamp":1494931365000},"page":"394-405","source":"Crossref","is-referenced-by-count":24,"title":["Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study"],"prefix":"10.1097","volume":"1","author":[{"given":"Tomomi","family":"Kogiso","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University,Tokyo,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Egawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Gastroenterology,Tokyo Women's Medical University,Tokyo,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics,Kyoto Prefectural University of Medicine Graduate School of Medical Science,Kyoto,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Taniai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University,Tokyo,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University,Tokyo,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Tokushige","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University,Tokyo,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Sakisaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology,Fukuoka University,Fukuoka,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Sakabayashi","sequence":"additional","affiliation":[{"name":"Center for Quality Assurance in Research and Development,Kyoto Prefectural University of Medicine,Kyoto,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Gastroenterology,Tokyo Women's Medical University,Tokyo,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Umeshita","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine,Osaka University,Osaka,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine,Kyoto University,Kyoto,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"hep41037-bib-0001-20240114","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"hep41037-bib-0002-20240114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hepr.12615","article-title":"It is time to change primary biliary cirrhosis (PBC): new nomenclature from \u201ccirrhosis\u201d to \u201dcholangitis\u201d, and upcoming treatment based on unveiling pathology","volume":"46","year":"2016","journal-title":"Hepatol Res"},{"key":"hep41037-bib-0003-20240114","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"hep41037-bib-0004-20240114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","year":"1982","journal-title":"N Engl J Med"},{"key":"hep41037-bib-0005-20240114","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"hep41037-bib-0006-20240114","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0007-20240114","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long\u2010term follow\u2010up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","year":"2006","journal-title":"Clin Transplant"},{"key":"hep41037-bib-0008-20240114","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post\u2010liver transplant","volume":"11","year":"2005","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0009-20240114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(03)00283-6","article-title":"Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence","volume":"39","year":"2003","journal-title":"J Hepatol"},{"key":"hep41037-bib-0010-20240114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long\u2010term pathologic study","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0011-20240114","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0012-20240114","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","article-title":"Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody\u2010subtypes after transplantation","volume":"20","year":"1994","journal-title":"J Hepatol"},{"key":"hep41037-bib-0013-20240114","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510240517","article-title":"Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis","volume":"24","year":"1996","journal-title":"Hepatology"},{"key":"hep41037-bib-0014-20240114","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"hep41037-bib-0015-20240114","first-page":"S455","article-title":"Long\u2010term clinical outcome of living\u2010donor liver transplantation for primary biliary cirrhosis","volume":"37","year":"2007","journal-title":"Hepatol Res"},{"key":"hep41037-bib-0016-20240114","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0017-20240114","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long\u2010term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep41037-bib-0018-20240114","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0019-20240114","doi-asserted-by":"crossref","first-page":"116","DOI":"10.12659\/AOT.892394","article-title":"Relevance of male\u2010to\u2010female sex mismatch in liver transplantation for primary biliary cirrhosis","volume":"20","year":"2015","journal-title":"Ann Transplant"},{"key":"hep41037-bib-0020-20240114","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long\u2010term outcomes of living\u2010donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"hep41037-bib-0021-20240114","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"hep41037-bib-0022-20240114","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.transproceed.2005.03.130","article-title":"Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival","volume":"37","year":"2005","journal-title":"Transplant Proc"},{"key":"hep41037-bib-0023-20240114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cgh.2006.09.031","article-title":"Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis","volume":"5","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"key":"hep41037-bib-0024-20240114","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","article-title":"Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis","volume":"48","year":"2015","journal-title":"Clin Rev Allergy Immunol."},{"key":"hep41037-bib-0025-20240114","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2188\/jea.16.30","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid","volume":"16","year":"2006","journal-title":"J Epidemiol."},{"key":"hep41037-bib-0026-20240114","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"hep41037-bib-0027-20240114","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel","volume":"31","year":"2000","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"hep41037-bib-0028-20240114","first-page":"S463","article-title":"Histological recurrence of autoimmune liver diseases after living\u2010donor liver transplantation","volume":"37","year":"2007","journal-title":"Hepatol Res"},{"key":"hep41037-bib-0029-20240114","first-page":"173","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","year":"1993","journal-title":"J Hepatol"},{"key":"hep41037-bib-0030-20240114","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","year":"1967","journal-title":"Proc R Soc Med"},{"key":"hep41037-bib-0031-20240114","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","year":"1995","journal-title":"Hepatology"},{"key":"hep41037-bib-0032-20240114","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","year":"1989","journal-title":"Nutrition"},{"key":"hep41037-bib-0033-20240114","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.transproceed.2007.02.061","article-title":"Warm ischemia in transplantation: search for a consensus definition","volume":"39","year":"2007","journal-title":"Transplant Proc"},{"key":"hep41037-bib-0034-20240114","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","year":"1983","journal-title":"J Clin Oncol"},{"key":"hep41037-bib-0035-20240114","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long\u2010term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0036-20240114","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1432-2277.2011.01336.x","article-title":"Long\u2010term outcome of living donor liver transplantation for primary biliary cirrhosis","volume":"25","year":"2012","journal-title":"Transpl Int"},{"key":"hep41037-bib-0037-20240114","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2001.25357","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow\u2010up study","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"hep41037-bib-0038-20240114","article-title":"First\u2010degree living\u2010related donor liver transplantation in autoimmune liver diseases","year":"2016","journal-title":"Am J Transplant"},{"key":"hep41037-bib-0039-20240114","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"hep41037-bib-0040-20240114","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"hep41037-bib-0041-20240114","first-page":"633","article-title":"Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes","volume":"9","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"hep41037-bib-0042-20240114","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"hep41037-bib-0043-20240114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(89)90643-4","article-title":"Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow\u2010up studies","volume":"97","year":"1989","journal-title":"Gastroenterology"},{"key":"hep41037-bib-0044-20240114","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.1840180617","article-title":"Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation","volume":"18","year":"1993","journal-title":"Hepatology"},{"key":"hep41037-bib-0045-20240114","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation","volume":"26","year":"1997","journal-title":"Hepatology"},{"key":"hep41037-bib-0046-20240114","first-page":"289","article-title":"Ductular damage in liver transplant rejection: its similarity to that of primary biliary cirrhosis and graft\u2010versus\u2010host disease","volume":"16","year":"1981","journal-title":"Pathol Annu"},{"key":"hep41037-bib-0047-20240114","first-page":"1009","article-title":"Aberrant expression of HLA\u2010DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis","volume":"2","year":"1984","journal-title":"Lancet"},{"key":"hep41037-bib-0048-20240114","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.1840160616","article-title":"Susceptibility to primary biliary cirrhosis is associated with the HLA\u2010DR8\u2010DQB1*0402 haplotype","volume":"16","year":"1992","journal-title":"Hepatology"},{"key":"hep41037-bib-0049-20240114","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.24113","article-title":"Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep41037-bib-0050-20240114","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2249.2009.04005.x","article-title":"Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis","volume":"158","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"hep41037-bib-0051-20240114","first-page":"168","article-title":"Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid","volume":"39","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"hep41037-bib-0052-20240114","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/TP.0b013e3181874a36","article-title":"Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin","volume":"86","year":"2008","journal-title":"Transplantation."},{"key":"hep41037-bib-0053-20240114","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1189\/jlb.0904503","article-title":"Concentrations of cyclosporin A and FK506 that inhibit IL\u20102 induction in human T cells do not affect TGF\u2010beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF\u2010beta1","volume":"77","year":"2005","journal-title":"J Leukoc Biol."},{"key":"hep41037-bib-0054-20240114","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant."},{"key":"hep41037-bib-0055-20240114","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0026-0495(93)90056-T","article-title":"The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities","volume":"42","year":"1993","journal-title":"Metabolism"},{"key":"hep41037-bib-0056-20240114","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00535-006-1831-0","article-title":"Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels","volume":"41","year":"2006","journal-title":"J Gastroenterol"},{"key":"hep41037-bib-0057-20240114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.hepres.2004.04.001","article-title":"Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis","volume":"29","year":"2004","journal-title":"Hepatol Res"},{"key":"hep41037-bib-0058-20240114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long\u2010term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep4.1037","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/02009842-201707000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:17:46Z","timestamp":1705249066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02009842-201707000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1037","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,16]]}}}